Suppr超能文献

用于黏膜递送人类免疫缺陷病毒抑制剂氰苷菌素-N的工程化阴道乳酸杆菌菌株。

Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N.

作者信息

Liu Xiaowen, Lagenaur Laurel A, Simpson David A, Essenmacher Kirsten P, Frazier-Parker Courtney L, Liu Yang, Tsai Daniel, Rao Srinivas S, Hamer Dean H, Parks Thomas P, Lee Peter P, Xu Qiang

机构信息

Osel, Inc, Santa Clara, CA 95054, USA.

出版信息

Antimicrob Agents Chemother. 2006 Oct;50(10):3250-9. doi: 10.1128/AAC.00493-06.

Abstract

Women are at significant risk of human immunodeficiency virus (HIV) infection, with the cervicovaginal mucosa serving as a major portal for virus entry. Female-initiated preventatives, including topical microbicides, are urgently needed to help curtail the HIV/AIDS pandemic. Here we report on the development of a novel, live microbicide that employs a natural vaginal strain of Lactobacillus jensenii engineered to deliver the potent HIV inhibitor cyanovirin-N (CV-N). To facilitate efficient expression of CV-N by this bacterium, the L. jensenii 1153 genome was sequenced, allowing identification of native regulatory elements and sites for the chromosomal integration of heterologous genes. A CV-N expression cassette was optimized and shown to produce high levels of structurally intact CV-N when expressed in L. jensenii. Lactobacillus-derived CV-N was capable of inhibiting CCR5-tropic HIV(BaL) infectivity in vitro with a 50% inhibitory concentration of 0.3 nM. The CV-N expression cassette was stably integrated as a single copy into the bacterial chromosome and resolved from extraneous plasmid DNA without adversely affecting the bacterial phenotype. This bacterial strain was capable of colonizing the vagina and producing full-length CV-N when administered intravaginally to mice during estrus phase. The CV-N-producing Lactobacillus was genetically stable when propagated in vitro and in vivo. This work represents a major step towards the development of an inexpensive yet durable protein-based microbicide to block the heterosexual transmission of HIV in women.

摘要

女性面临着感染人类免疫缺陷病毒(HIV)的重大风险,宫颈阴道黏膜是病毒进入的主要门户。迫切需要女性主导的预防措施,包括局部用杀菌剂,以帮助遏制HIV/艾滋病的流行。在此,我们报告了一种新型活杀菌剂的研发情况,该杀菌剂采用经基因工程改造的詹氏乳杆菌天然阴道菌株来递送强效HIV抑制剂蓝藻素-N(CV-N)。为便于该细菌高效表达CV-N,对詹氏乳杆菌1153的基因组进行了测序,从而能够鉴定天然调控元件以及异源基因的染色体整合位点。对CV-N表达盒进行了优化,结果表明在詹氏乳杆菌中表达时可产生高水平的结构完整的CV-N。源自乳杆菌的CV-N能够在体外抑制CCR5嗜性HIV(BaL)的感染性,其50%抑制浓度为0.3 nM。CV-N表达盒作为单拷贝稳定整合到细菌染色体中,并与外源质粒DNA分离,且未对细菌表型产生不利影响。在发情期将该细菌菌株经阴道给予小鼠时,它能够在阴道定植并产生全长CV-N。产生CV-N的乳杆菌在体外和体内繁殖时遗传稳定。这项工作朝着开发一种廉价且持久的基于蛋白质的杀菌剂迈出了重要一步,该杀菌剂可阻断HIV在女性中的异性传播。

相似文献

1
2
Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.
Mucosal Immunol. 2011 Nov;4(6):648-57. doi: 10.1038/mi.2011.30. Epub 2011 Jul 6.
3
Engineering of a human vaginal Lactobacillus strain for surface expression of two-domain CD4 molecules.
Appl Environ Microbiol. 2008 Aug;74(15):4626-35. doi: 10.1128/AEM.00104-08. Epub 2008 Jun 6.
6
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4.
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11672-7. doi: 10.1073/pnas.1934747100. Epub 2003 Sep 12.
8
Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models.
AIDS Res Hum Retroviruses. 2004 Jan;20(1):11-8. doi: 10.1089/088922204322749459.
9
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers.
Antimicrob Agents Chemother. 2010 Jul;54(7):2994-3001. doi: 10.1128/AAC.01492-09. Epub 2010 May 17.

引用本文的文献

1
Metabolic engineering of Lactobacilli spp. for disease treatment.
Microb Cell Fact. 2025 Mar 6;24(1):53. doi: 10.1186/s12934-025-02682-4.
2
Research and application of intelligent diagnosis and treatment engineering bacteria.
Front Bioeng Biotechnol. 2024 Dec 18;12:1524376. doi: 10.3389/fbioe.2024.1524376. eCollection 2024.
3
Engineered bacteria as drug delivery vehicles: Principles and prospects.
Eng Microbiol. 2022 Jun 21;2(3):100034. doi: 10.1016/j.engmic.2022.100034. eCollection 2022 Sep.
4
Harnessing the power within: engineering the microbiome for enhanced gynecologic health.
Reprod Fertil. 2024 Apr 15;5(2). doi: 10.1530/RAF-23-0060. Print 2024 Apr 1.
6
Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms.
Nat Biotechnol. 2023 Aug;41(8):1089-1098. doi: 10.1038/s41587-022-01584-9. Epub 2023 Jan 19.
7
Recent Advances in the Excipients Used in Modified Release Vaginal Formulations.
Materials (Basel). 2022 Jan 3;15(1):327. doi: 10.3390/ma15010327.
8
Algal and Cyanobacterial Lectins and Their Antimicrobial Properties.
Mar Drugs. 2021 Dec 1;19(12):687. doi: 10.3390/md19120687.
9
The Vaginal Microbiome of Nonhuman Primates Can Be Only Transiently Altered to Become Dominant without Reducing Inflammation.
Microbiol Spectr. 2021 Dec 22;9(3):e0107421. doi: 10.1128/Spectrum.01074-21. Epub 2021 Nov 10.
10
Evaluation of Microalgae Antiviral Activity and Their Bioactive Compounds.
Antibiotics (Basel). 2021 Jun 20;10(6):746. doi: 10.3390/antibiotics10060746.

本文引用的文献

1
Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin.
J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):512-20. doi: 10.1097/01.qai.0000187446.76579.d3.
2
Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide.
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):11993-8. doi: 10.1073/pnas.0504881102. Epub 2005 Jul 22.
3
HIV/AIDS in women: an expanding epidemic.
Science. 2005 Jun 10;308(5728):1582-3. doi: 10.1126/science.1112489.
5
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
J Infect Dis. 2005 May 1;191(9):1403-9. doi: 10.1086/429411. Epub 2005 Mar 30.
9
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
Science. 2004 Oct 15;306(5695):485-7. doi: 10.1126/science.1099288.
10
Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods.
Microbiology (Reading). 2004 Aug;150(Pt 8):2565-2573. doi: 10.1099/mic.0.26905-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验